Polymer Capital Management (Hk) LTD Terns Pharmaceuticals, Inc. Transaction History
Polymer Capital Management (Hk) LTD
- $587 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Hk) LTD transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Polymer Capital Management (Hk) LTD holds 239,110 shares of TERN stock, worth $903,835. This represents 0.11% of its overall portfolio holdings.
Number of Shares
239,110
Previous 177,000
35.09%
Holding current value
$903,835
Previous $981 Million
32.7%
% of portfolio
0.11%
Previous 0.17%
Shares
3 transactions
Others Institutions Holding TERN
# of Institutions
143Shares Held
84.5MCall Options Held
256KPut Options Held
133K-
Soleus Capital Management, L.P. Greenwich, CT8.17MShares$30.9 Million1.87% of portfolio
-
Orbimed Advisors LLC San Diego, CA7.56MShares$28.6 Million0.65% of portfolio
-
Morgan Stanley New York, NY7.11MShares$26.9 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA6.9MShares$26.1 Million5.17% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.58MShares$21.1 Million0.54% of portfolio
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $142M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...